Navigation Links
'Land grabs' for rice production due to supply threats
Date:9/28/2009

"To put it simply, there is not enough rice to feed the world," says Dr. Robert Zeigler, director general of the International Rice Research Institute (IRRI).

"To meet the need and keep rice prices around US$300 a ton which allows poor rice farmers to make some profit yet keeps rice affordable for poor rice consumers we need to produce an additional 8󈝶 million tons of rice more than in the previous year for the next twenty years."

Many countries do not have the capacity to grow enough rice on their own land to meet existing or anticipated demand. To meet their needs governments or the private sector import rice and some are exploring ways to invest in rice production or rice-growing land in other countries.

IRRI is not involved in any projects on land acquisition for rice production, nor does it provide advice on land acquisition, but it does find ways to help increase the overall rice supply with a mandate to help poor rice farmers and consumers and improve environmental health.

"IRRI's primary focus is on helping farmers increase the productivity of rice farms on existing rainfed and irrigated land and do it in a sustainable manner," says Dr. Zeigler. "Expanding rice-growing areas into previously uncultivated areas is considered a last option and this must be done with great care."

As a nonprofit and independent organization, IRRI shares its scientific solutions and knowledge broadly with a range of different stakeholders, including farmers, and across the public and private sector. By doing this, IRRI contributes to improving rice production and the welfare of rice farmers in the broadest possible way, giving farmers more options to choose from.

Dr. Zeigler acknowledges that "many developing countries would benefit from financial investment in their rice industry to help them develop in a sustainable way, reach their potential, and benefit local rice farmers and consumers."

"For IRRI, the most important thing ab
'/>"/>

Contact: Sophie Clayton
s.clayton@cgiar.org
63-917-552-6082
International Rice Research Institute
Source:Eurekalert

Page: 1 2

Related biology news :

1. New NIST trace explosives standard slated for homeland security duty
2. Shrinking Bylot Island glaciers tell story of climate change
3. Small rodents encourage the formation of scrubland in Spain
4. Searching for an interglacial on Greenland
5. Carnegie donates landmark clones to biology
6. Shifting Sands highlights past, present and future of Maryland coastal bays ecosystem
7. Red List overlooks island species
8. Noise pollution negatively affects woodland bird communities, says CU-Boulder study
9. Wolf reintroduction proposed in Scottish Highland test case
10. Landmark project to map genomics of complex ant systems
11. Data published in the New England Journal of Medicine support use of raxibacumab (ABthrax) for the treatment of inhalation anthrax
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2015)... , July 9, 2015  Synaptics Inc. (NASDAQ: SYNA ... today that it will report financial results for the ... 30, 2015 after the close of market. The company ... investors at 2:00 p.m. PT (5:00 p.m. ET), during ... To participate on the live call, analysts and investors ...
(Date:7/9/2015)... Calif. , July 9, 2015  Unchained ... today announcing its acquisition of Avid Nano. Avid ... light scattering (DLS) systems.    Also ... smallest, fastest and easiest to use protein sizing ... that measures a protein,s hydrodynamic size, size distribution, ...
(Date:7/8/2015)... -- Summary Pancreatic cancer is the 12th most ... a mortality rate of 10.9 deaths per 100,000 people ... has highlighted a significant need for new and improved ... the current market. A highly active pancreatic cancer ... types and mechanisms of action, which provides a striking ...
Breaking Biology News(10 mins):Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3
... 8th, 2011, Shenzhen, China BGI, the world,s largest ... People,s Hospital, announced today that the study on frequent ... (TCC) of the bladder was published online in ... basis for future studies on TCC, suggesting that aberration ...
... A repellant for sea lampreys could be the key to ... the Great Lakes, says a Michigan State University researcher. ... When scents from dead sea lampreys are poured into a ... dramatic. In the past, these reactions were simply dismissed as ...
... demise of the world,s forests some 250 million years ... by global climate change, according to a new study ... Dutch and British colleagues. The researchers do ... could cause a similar increase in pathogenic soil bacteria ...
Cached Biology News:Research discovers frequent mutations of chromatin remodeling genes in TCC of the bladder 2Sea lampreys fear the smell of death 2Did past climate change encourage tree-killing fungi? 2Did past climate change encourage tree-killing fungi? 3
(Date:7/28/2015)... , July 28, 2015 Tauriga Sciences, ... diversified life sciences company, today announced that its stockholders ... of common stock of the Company from 1,000,000,000 to ... July 27, 2015 at the Law Offices of Nixon ... the Special Meeting, there were 480,655,929 shares of common ...
(Date:7/28/2015)... , July 28, 2015  Moerae Matrix ... Phase 1 clinical trial with MMI-0100, a first-in-class ... being developed for pulmonary disorders characterized by inflammation ... United Kingdom , is a double-blind, ... evaluating the safety and tolerability of MMI-0100 when ...
(Date:7/28/2015)... July 28, 2015 CSL Behring ... has accepted for review the company,s Biologics License Application ... (rVIII-SingleChain) for the treatment of hemophilia A. In the ... Hemophilia A is a congenital ... nearly all affected patients are male. People with hemophilia ...
(Date:7/28/2015)... RESEARCH TRIANGLE PARK, N.C., July 28, 2015  United ... its financial results for the second quarter ended ... nearly 300% as compared to the second quarter ... said Roger Jeffs, Ph.D., United Therapeutics, President and ... was due to an increase in the number ...
Breaking Biology Technology:Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 2Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 3Moerae Initiates Lipopolysaccharide (LPS) Challenge Study of Inhaled MMI-0100 for Pulmonary Disease Following Encouraging Safety and Tolerability Observed in Single Ascending Dose Phase 1 Study 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 3United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 2United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 3United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 4United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 5United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 6United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 7United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 8United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 9United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 10United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 11
... NORRISTOWN, Pa., Nov. 4 Emerson Resources, ... announced that it has formed a strategic partnership with ... organization that specializes in the agrichemical and related industries, ... partnership leverages the expertise of industry veteran Robert Westbrook, ...
... (Nasdaq: OSTE ), a leader in the emerging field ... entered into a multi-year tissue supply agreement with Community Tissue ... This new agreement replaces an existing contract between the two ... terms of the agreement, CTS will supply Osteotech with a ...
... LTCI NOW is created ... , ... -- IMULAN BioTherapeutics, LLC has developed the LTCI NOW program in an effort to ... and feline leukemia virus (FeLV). Like Human Immunodeficiency Virus (HIV), FIV and FeLV are retroviral ...
Cached Biology Technology:Emerson Resources Forges Strategic Partnership with Bio Research 2Osteotech Secures 10-Year Tissue Supply Agreement 2Osteotech Secures 10-Year Tissue Supply Agreement 3New Program Developed in the Fight Against Feline Aids 2
EPA II Buffer is a diluent formulated to stabilize the activity of Chemicon horseradish peroxidase (HRP)-antibody conjugates at high conjugate dilution for extended periods....
... Mouse polyclonal antibody raised against ... Immunogen: K6HF ... a.a) partial recombinant protein with ... Accession Number: NM_004693 ...
... screen, without Camera • ... mega pixel resolution. It is computer free for ... from large 5.6" TFT color liquid crystal display ... capture image for fluorescent gels, colorimetric gels, auto ...
... Visualizer DX's sensitivity of DNA detection has been ... in an agarose gel can be detected > ... can be purified by organic solvent extraction or ... kits worked well.) DNA excised from agarose ...
Biology Products: